LumiraDx
London
About LumiraDx
LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance. It offers proven solutions to help achieve health care transformation goals, practically and reliably, in the here and now. The company's clients universally deliver more integrated, more informed, patient-centered care that is safer, more efficient, and with demonstrably better outcomes. LumiraDx makes diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences, and better value. The diagnostic system platform combines a small, portable instrument, advanced low-cost test strip, and seamless digital connectivity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $310.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2023)
- Ticker: nasdaq:LMDX
- Website: lumiradx.comhome
- Phone: 44 1172 842 535
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lumiradx-95763 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.